Literature DB >> 33225

Isolation of type-specific polysaccharide antigen from group B type Ib streptococci.

J Y Tai, E C Gotschlich, R C Lancefield.   

Abstract

Group B streptococcus type Ib (strain H36B) was subjected to digestion with extracellular muralytic enzymes prepared from Streptomyces albus. Type Ib-specific polysaccharide antigen was isolated from the lysate by alcohol precipitation and Sepharose 6B chromatography. The purified type Ib antigen has a Kd value of 0.31 on a Sepharose 4B column and contains four sugars, galactose, glucose, N-acetyl glucosamine, and sialic acid in a molar ratio of 2.05:0.86:1.00:0.90. Acid treatment (pH 2.0) of this polysaccharide results in partial degradation of the antigen (Kd = 0.41 on Sepharose 4B) with the loss of 93% of the sialic acid. The molar ratio of the remaining sugars in the polysaccharide remains identical to that in the native one. This suggests that the sialic acid is at the terminal position in the molecule. Both intact and acid-treated antigen cross-react with some type Ia and type Ic antisera as a result of the common Iabc determinant, but not with type II and type III antisera. Absorption studies indicate that Ib-specific determinant and Iabc determinant are on the same molecule and that sialic acid is not the cross-reactive determinant.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 33225      PMCID: PMC2184730          DOI: 10.1084/jem.149.1.58

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  The isolation and some physiochemical and biologic properties of the type 3 antigen of group B streptococci.

Authors:  H Russell; N L Norcross
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

2.  Antigenic properties of the hexosamine polymer of streptococcal mucopeptide.

Authors:  W W Karakawa; H Lackland; R M Krause
Journal:  J Immunol       Date:  1967-12       Impact factor: 5.422

3.  Immunochemistry of purified polysaccharide type antigens of group B streptococcal types Ia, Ib, and Ic.

Authors:  H W Wilkinson
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

4.  Existence of multiple immunodeterminants in the type-specific capsular substance of group B type Ia streptococci.

Authors:  J A Kane; W W Karakawa
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

5.  Complete amino acid analysis of proteins from a single hydrolysate.

Authors:  R J Simpson; M R Neuberger; T Y Liu
Journal:  J Biol Chem       Date:  1976-04-10       Impact factor: 5.157

6.  Chicken embryo model for type III group B beta-hemolytic streptococcal septicemia.

Authors:  J Tieffenberg; L Vogel; R R Kretschmer; D Padnos; S P Gotoff
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

7.  Extracellular neuraminidase production by group B streptococci.

Authors:  T W Milligan; D C Straus; S J Mattingly
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

8.  Multiple polysaccharide antigens of group B streptococcus, type Ia: emphasis on a sialic acid type-specific polysaccharide.

Authors:  J A Kane; W W Karakawa
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

9.  Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.

Authors:  R C Lancefield; M McCarty; W N Everly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

10.  Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus.

Authors:  C J Baker; D L Kasper; C E Davis
Journal:  J Exp Med       Date:  1976-02-01       Impact factor: 14.307

View more
  15 in total

1.  Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid.

Authors:  T Lagergard; J Shiloach; J B Robbins; R Schneerson
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

2.  Immunospecificity and quantitation of an enzyme-linked immunosorbent assay for group B streptococcal antibody.

Authors:  B F Anthony; N F Concepcion; S A McGeary; J I Ward; D C Heiner; P Shapshak; R A Insel
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

3.  Factors influencing release of type III antigens by group B streptococci.

Authors:  T I Doran; D C Straus; S J Mattingly
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

4.  Extracellular antigens of serotype III group B streptococci.

Authors:  T I Doran; D C Straus; S J Mattingly
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

5.  Purification and partial characterization of neuraminidase from type III group B streptococci.

Authors:  T W Milligan; S J Mattingly; D C Straus
Journal:  J Bacteriol       Date:  1980-10       Impact factor: 3.490

6.  Blocking adhesion of cancer cells to endothelial cell types by S. agalactiae type-specific polysaccharides.

Authors:  K Miyake; S Yamamoto; S Iijima
Journal:  Cytotechnology       Date:  1996       Impact factor: 2.058

7.  Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus.

Authors:  T I Doran; S J Mattingly
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  Protective levels of human immunoglobulin G antibody to group B streptococcus type Ib.

Authors:  K M Boyer; L S Kendall; C K Papierniak; M E Klegerman; S P Gotoff
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

9.  Isolation, chemical composition, and molecular size of extracellular type II and type Ia polysaccharides of group B streptococci.

Authors:  B J De Cueninck; T F Greber; T K Eisenstein; R M Swenson; G D Shockman
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

10.  Structure and serology of the native polysaccharide antigen of type Ia group B streptococcus.

Authors:  H J Jennings; K G Rosell; D L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.